M Ottiger, MA Thiel, U Feige, P Lichtlen, DM Urech - … Ophthalmology & Visual …, 2009 - ARVO RESULTS. After topical administration as eye drops, without a penetration enhancer, ESBA105 reached
therapeutic levels in the anterior and posterior segment of the eye. ESBA105 migrated to aqueous
humor via corneal penetration and ... Cited by 6 - Related articles - All 3 versions
H Liu, WWY Kao - Molecular Vision, 2009 - pubmedcentral.nih.gov Adult mouse corneas were fixed overnight in 4% paraformaldehyde or a mixture of 4% paraformaldehyde
and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, at 4 °C. After washing with 0.1% Triton
X-100, corneas were embedded in 1% ... Related articles - All 4 versions
H Nomoto, F Shiraga, N Kuno, E Kimura, S Fujii, K … - … Ophthalmology & Visual …, 2009 - ARVO RESULTS. After intravitreal injection in the treated eye, the mean maximum concentrations (C max )
of bevacizumab in the iris/ciliary body and retina/choroid were 109,192.6, and 93,990.0 ng/g,
respectively, whereas after ... Related articles - All 3 versions